DOCSLIB.ORG

Manual for Psychedelic Guides

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Manual for Psychedelic Guides Manual for Psychedelic Guides Date: Draft version: January 7, 2019 Author: Mark Haden, With significant contributions by: Martin Ball PdD, Dr. Birgitta Woods Location: Vancouver, British Columbia Contact Information: [email protected] Table of Contents Choice of Language in This Manual............................................................................... 4 Introduction .................................................................................................................... 4 Set and Setting .............................................................................................................. 5 Ritualizing the Process .................................................................................................. 6 Inner Healing Intelligence .............................................................................................. 8 The Role of the Guide .................................................................................................... 8 Qualities of Guides ......................................................................................................... 8 A Knowledgeable, Skilled and Wise Guide: ........................................................ 9 Experiential Knowledge: ...................................................................................... 9 Knowledge of the Human Mind When Seen Through the Lens of Psychedelics . 9 Knowledge of the Power and Importance of Human Relationships ................... 10 Appreciation for Human Suffering ..................................................................... 10 The Skills of Being a Psychedelic Guide ...................................................................... 11 The Six Core Competencies ............................................................................. 15 1) Empathetic Abiding Presence ............................................................ 15 2) Trust Enhancement ........................................................................... 16 3) Spiritual Intelligence ........................................................................... 16 4) Knowledge ......................................................................................... 17 5) Guide Self-Awareness and Ethical Integrity ....................................... 17 6) Proficiency in complementary techniques .......................................... 17 Trauma resolution skills ............................................................................ 17 Physical Touch .................................................................................................. 18 Eye Contact ....................................................................................................... 18 Body Language ................................................................................................. 18 Therapeutic Alliance .......................................................................................... 19 Should a Guide Take a Psychedelic at the Same Time as the Participant? ...... 20 Preparation Sessions ................................................................................................... 20 Screening .......................................................................................................... 21 Challenging Situations as a Result of Poor Screening ...................................... 22 Information Sharing and Clarification of Intent and Process ............................. 22 Dosage .............................................................................................................. 25 Informed Consent Process ................................................................................ 26 The Areas Covered by the Informed Consent Form ................................. 26 Confidentiality ........................................................................................... 26 Guiding the Session ..................................................................................................... 27 Number of Guides ............................................................................................. 27 Items Which Should be Available ...................................................................... 27 Music ................................................................................................................. 28 As the Participant Arrives for the Session ......................................................... 29 2 Beginning of the Session – Treatment Room .................................................... 29 Dealing with Specific Behaviours ................................................................................. 31 Talking During the Beginning and Middle of the Session .................................. 31 Moving Around the Room.................................................................................. 32 Moving Unpredictably ........................................................................................ 32 Asking the Guide Personal Questions ............................................................... 32 Becoming Increasingly Anxious and Agitated ................................................... 32 If the Participant is Extremely Emotional ........................................................... 33 Trying to Leave the Space ................................................................................ 33 Going to the Bathroom ...................................................................................... 33 Vomiting ............................................................................................................ 34 Urine or Bowel Release .................................................................................... 34 Fire Alarm or Earthquake .................................................................................. 34 Cuddling ............................................................................................................ 34 During the Last Part of the Session ............................................................................. 34 Bringing Resolution to Turbulence at the Ending of a Session .................................... 35 Concluding the Session ............................................................................................... 36 Post-Session Debrief ................................................................................................... 37 Behaviours to Avoid ..................................................................................................... 37 Offer What You Have ................................................................................................... 37 Integration .................................................................................................................... 37 The Goals of the Integration Process are: ......................................................... 38 The Initial Process of Integration: ...................................................................... 38 Integration Over Time ....................................................................................... 39 Code of Ethics.............................................................................................................. 39 Integrity: ............................................................................................................ 39 Competence: ..................................................................................................... 39 Health and Safety: ............................................................................................. 40 Healthy Boundaries: .......................................................................................... 40 Compassionate Empathetic Presence: ............................................................. 40 Being a Psychedelic Guide ............................................................................... 41 Being a Functional Member of a Team ............................................................. 41 Suggested Reading ..................................................................................................... 44 3 Choice of Language in This Manual The word “guide” is chosen for the individual(s) who oversee a psychedelic therapy session, as it is a broad, encompassing term which implies the appropriate level of intervention: somewhere between the overly active role of “therapist”, and the inactive role of “sitter”. It is assumed that the guide is able, when appropriate, to demonstrate the skills of both a therapist and a sitter. The word “guide” was also chosen because it allows for the inclusion of staff with a wide range of backgrounds, as a truly multidisciplinary approach is required. The word “treatment” is used instead of “therapy”, as this is a broader term which is more encompassing of the desired “non-directive” approach. The word “participant” is used instead of “subject”, as this word more accurately reflects their “active participation” and “empowerment to change”, which is foundational to this treatment process. Introduction The practice of working with psychedelics for healing or spiritual purposes is not new. Many indigenous traditions have used “sacred medicines” in ceremonial healing and spiritual contexts for centuries and underground therapists have been working with psychedelics in healing practices for decades. There are many different approaches and medicines (and combinations of medicines) used in individual, group, couple and family contexts.
Load more

Recommended publications
  • Reviewing the Heroic Experience: a Humanistic and Existential Counselling Perspective
    Heroism Science Volume 4 Issue 1 Article 6 2019 Reviewing the Heroic Experience: A Humanistic and Existential Counselling Perspective Peter Bray University of Auckland, [email protected] Peter James University of Auckland, [email protected] Follow this and additional works at: https://scholarship.richmond.edu/heroism-science Part of the Counseling Psychology Commons, and the Developmental Psychology Commons Recommended Citation Bray, Peter and James, Peter (2019) "Reviewing the Heroic Experience: A Humanistic and Existential Counselling Perspective," Heroism Science: Vol. 4 : Iss. 1 , Article 6. DOI: 10.26736/hs.2019.01.06 Available at: https://scholarship.richmond.edu/heroism-science/vol4/iss1/6 This Article is brought to you for free and open access by UR Scholarship Repository. It has been accepted for inclusion in Heroism Science by an authorized editor of UR Scholarship Repository. For more information, please contact [email protected]. 1 Heroism Science: An Interdisciplinary Journal (ISSN 2573- 7120) https://scholarship.richmond.edu/heroism-science/ Vol. 4 No. 1 (2019) pp. 1-34 Reviewing the Heroic Experience: A Humanistic and Existential Counselling Perspective PETER BRAY1 University of Auckland [email protected] PETER JAMES University of Auckland [email protected] ABSTRACT: Taking a humanistic and existential counselling stance, this brief review of heroism and the heroic experience begins by discussing the utility and structure of Joseph Campbell’s (1949) monomythic narrative of the hero’s journey, whilst considering the Jungian conceptualisation of the archetype and the collective unconscious. With their shared assumptions about transformation and growth, modern psychology and the therapeutic practice of counselling and psychotherapy are reviewed in terms of their utilisation of the hero-journey as a developmental metaphor for clients, particularly in trauma recovery.
    [Show full text]
  • From Sacred Plants to Psychotherapy
    From Sacred Plants to Psychotherapy: The History and Re-Emergence of Psychedelics in Medicine By Dr. Ben Sessa ‘The rejection of any source of evidence is always treason to that ultimate rationalism which urges forward science and philosophy alike’ - Alfred North Whitehead Introduction: What exactly is it that fascinates people about the psychedelic drugs? And how can we best define them? 1. Most psychiatrists will define psychedelics as those drugs that cause an acute confusional state. They bring about profound alterations in consciousness and may induce perceptual distortions as part of an organic psychosis. 2. Another definition for these substances may come from the cross-cultural dimension. In this context psychedelic drugs may be recognised as ceremonial religious tools, used by some non-Western cultures in order to communicate with the spiritual world. 3. For many lay people the psychedelic drugs are little more than illegal and dangerous drugs of abuse – addictive compounds, not to be distinguished from cocaine and heroin, which are only understood to be destructive - the cause of an individual, if not society’s, destruction. 4. But two final definitions for psychedelic drugs – and those that I would like the reader to have considered by the end of this article – is that the class of drugs defined as psychedelic, can be: a) Useful and safe medical treatments. Tools that as adjuncts to psychotherapy can be used to alleviate the symptoms and course of many mental illnesses, and 1 b) Vital research tools with which to better our understanding of the brain and the nature of consciousness. Classifying psychedelic drugs: 1,2 The drugs that are often described as the ‘classical’ psychedelics include LSD-25 (Lysergic Diethylamide), Mescaline (3,4,5- trimethoxyphenylathylamine), Psilocybin (4-hydroxy-N,N-dimethyltryptamine) and DMT (dimethyltryptamine).
    [Show full text]
  • The Human Encounter with Death
    The Human Encounter With Death by STANISLAV GROF, M.D. & JOAN HALIFAX, PH.D. with a Foreword by ELISABETH KÜBLER-ROSS, M.D D 492 / A Dutton Paperback / $3.95 / In Canada $4.75 Stanislav Grof, M.D., and Joan Halifax, Ph.D., have a unique authority and competence in the interpretation of the human encounter with death. Theirs is an extraordin­ ary range of experience, in clinical research with psyche- delic substances, in cross-cultural and medical anthropology, and in the analysis of Oriental and archaic literatures. Their pioneering work with psychedelics ad­ ministered to individuals dying of cancer opened domains of experience that proved to be nearly identical to those al­ ready mapped in the "Books of the Dead," those mystical visionary accounts of the posthumous journeys of the soul. The Grof/Halifax book and these ancient resources both show the imminent experience of death as a continuation of what had been the hidden aspect of the experience of life. —Joseph Campbell The authors have assisted persons dying of cancer in tran­ scending the anxiety and anger around their personal fate. Using psychedelics, they have guided the patients to death- rebirth experiences that resemble transformation rites practiced in a variety of cultures. Physician and medical anthropologist join here in recreating an old art—the art of dying. —June Singer The Human Encounter With Death is the latest of many re­ cent publications in the newly evolving field of thanatology. It is, however, a quite different kind of book—one that be­ longs in every library of anyone who seriously tries to un­ derstand the phenomenon we call death.
    [Show full text]
  • Ritualized Peyote Use Can Facilitate Mental Health, Social Solidarity
    Ritualized Peyote Use Can Facilitate Mental Health, Social Solidarity, and Cultural Survival: A Case Study of the Religious and Mystical Experiences in the Wixárika People of the Sierra Madre Occidental The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Luce, Nathan William. 2020. Ritualized Peyote Use Can Facilitate Mental Health, Social Solidarity, and Cultural Survival: A Case Study of the Religious and Mystical Experiences in the Wixárika People of the Sierra Madre Occidental. Master's thesis, Harvard Extension School. Citable link https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37365056 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Ritualized Peyote Use Can Facilitate Mental Health, Social Solidarity, and Cultural Survival: A Case Study of the Religious and Mystical Experiences in the Wixárika People of the Sierra Madre Occidental Nathan William Luce A Thesis in the Field of Religion for the Degree of Master of Liberal Arts in Extension Studies Harvard University May 2020 Copyright 2020 Nathan William Luce Abstract This paper examines how the Wixárika, or Huichol, as they are more commonly known to the outside world, have successfully engaged in a decade-long struggle to save their ceremonial homeland of Wirikuta. They have fended off a Canadian silver mining company’s attempts to dig mines in the habitat of their most important sacrament, peyote, using a remarkable combination of traditional and modern resistance techniques.
    [Show full text]
  • Psilocybin Mushrooms Fact Sheet
    Psilocybin Mushrooms Fact Sheet January 2017 What are psilocybin, or “magic,” mushrooms? For the next two decades thousands of doses of psilocybin were administered in clinical experiments. Psilocybin is the main ingredient found in several types Psychiatrists, scientists and mental health of psychoactive mushrooms, making it perhaps the professionals considered psychedelics like psilocybin i best-known naturally-occurring psychedelic drug. to be promising treatments as an aid to therapy for a Although psilocybin is considered active at doses broad range of psychiatric diagnoses, including around 3-4 mg, a common dose used in clinical alcoholism, schizophrenia, autism spectrum disorders, ii,iii,iv research settings ranges from 14-30 mg. Its obsessive-compulsive disorder, and depression.xiii effects on the brain are attributed to its active Many more people were also introduced to psilocybin metabolite, psilocin. Psilocybin is most commonly mushrooms and other psychedelics as part of various found in wild or homegrown mushrooms and sold religious or spiritual practices, for mental and either fresh or dried. The most popular species of emotional exploration, or to enhance wellness and psilocybin mushrooms is Psilocybe cubensis, which is creativity.xiv usually taken orally either by eating dried caps and stems or steeped in hot water and drunk as a tea, with Despite this long history and ongoing research into its v a common dose around 1-2.5 grams. therapeutic and medical benefits,xv since 1970 psilocybin and psilocin have been listed in Schedule I of the Controlled Substances Act, the most heavily Scientists and mental health professionals criminalized category for drugs considered to have a consider psychedelics like psilocybin to be “high potential for abuse” and no currently accepted promising treatments as an aid to therapy for a medical use – though when it comes to psilocybin broad range of psychiatric diagnoses.
    [Show full text]
  • Microgram Journal, Vol 2, Number 1
    Washington, D. C. Office of Science and Education Vol.II,No.1 Division of Laboratory Operations January 1969 INDEXISSUE CORRECTION 11 "Structure Elucidation of 'LBJ' , by Sander W. Bellman, John W. Turczan, James Heagy and Ted M. Hopes, Micro­ Gram .!., 3, 6-13 (Dec. 1968) Page 7, third and fourth sentences under Discussion: Change to read: "The melting point of the acid moiety found in step (g) was 148-150°c., compared to the litera­ ture, v~lue of 151°c for the melting point of benzilic acid (2); thus the benzilic acid melting point gives support to the proposed structure for 'LBJ'. Spectral evidence also supports the proposed structure". MICRO-GRAMREVISION Please re-number the pages of your copies of Micro-Gram, Volume I. Re-number pages bearing printing only. Vol­ ume I will then be numbered from page 1, the front page of issue No. 1, through page 189 the last page of issue No. 12. To help with this task, pages contained within each issue are as follows: Issue Number Page Through 1 1 8 2 9 29 3 30 32 4 33 66 5 67 79 6 80 97 7 98 120 8 121 128 9 129 136 10 137 157 11 158 170 12 171 189 CAUTION: Use of this publication should be restricted to forensic analysts or others having a legitimate need for this material. From the Archive Library of Erowid Center http://erowid.org/library/periodicals/microgram -2- CANNABIS ,·,-...__/' Attached is a copy of 11A Short Rapid Method for the Identification of Cannabis." The method was developed by Mro H.D.
    [Show full text]
  • Neural and Subjective Effects of Inhaled DMT in Natural Settings
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.19.258145; this version posted August 20, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Neural and subjective effects of inhaled DMT in natural settings Carla Pallavicini1,2 *, Federico Cavanna1,2, Federico Zamberlan1, Laura Alethia de la Fuente1, Mauricio Arias3, Celeste Romero4, Robin Carhart-Harris5, Christopher Timmermann5, Enzo Tagliazucchi1 * 1Departamento de Física, Universidad de Buenos Aires and Instituto de Física de Buenos Aires (IFIBA – CONICET), Pabellón I, Ciudad Universitaria (1428), CABA, Buenos Aires, Argentina 2Fundación para la lucha contra las enfermedades neurológicas de la infancia (FLENI), Montañeses 2325, C1428 CABA, Buenos Aires, Argentina 3Hospital General de Agudos Donación Francisco Santojanni, Pilar 950, C1408INH CABA, Buenos Aires, Argentina 4Centro de Estudios de la Cultura Cannábica (CECCa), Humahuaca 3947, C1192ACA CABA, Buenos Aires, Argentina 5Centre for Psychedelic Research, Department of Medicine, Imperial College London, Kensington, London SW7 2DD, United Kingdom *Corresponding authors: [email protected] , [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.19.258145; this version posted August 20, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract N,N-Dimethyltryptamine (DMT) is a short acting psychedelic tryptamine found naturally in many plants and animals.
    [Show full text]
  • CLINICAL STUDY PROTOCOL Psilocybin-Assisted Psychotherapy
    CLINICAL STUDY PROTOCOL Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma. Version: Final IND: [79,321] SPONSOR Multidisciplinary Association for Psychedelic PRINCIPAL INVESTIGATOR Sameet Kumar Ph.D. MEDICAL MONITOR Michael C. Mithoefer MD. STUDY PERSONNEL XXXXXXXXXXXXX XXXXXXXXXXXXX XXXXXXXXXXXXX STUDY MONITOR [CRA] Valerie Mojeiko IRB Study Site IRB Sponsor Signatory Rick Doblin Ph.D. Study Period 2008 For trial related emergencies please contact: Dr. Michael Mithoefer MAPS: S Kumar PI Clinical Study Protocol PCA1 Final December 1, 2007 Confidential Page 2 of 83 Table of Contents Introduction......................................................................................................................... 4 Background..................................................................................................................... 4 Disease History and Related Research ........................................................................... 5 Rationale ......................................................................................................................... 7 Summary......................................................................................................................... 7 Ethics................................................................................................................................... 8 Informed Consent of Subject .......................................................................................... 9 Recruitment and Screening............................................................................................
    [Show full text]
  • The Psychedelic Experience: the Importance of ‘Set’ and ‘Setting’
    The Psychedelic Experience: The Importance of ‘Set’ and ‘Setting’ Matthew Nour & Jacob Krzanowski Matthew Nour, CT1 in Psychiatry, South London and Maudsley NHS Foundation Trust; Jacob Krzanowski, CT1 in Psychiatry, South London and Maudsley NHS Foundation Trust. Email: [email protected] *Both authors contributed equally to this work We welcome the renewed interest in the therapeutic potential of psychedelic compounds. In their recent editorial, Sessa and Johnson1 echo the fervent research climate surrounding psychedelics spanning the 1950s and 60s. They suggest that psychedelics may cause prolonged changes in subjects’ personalities and attitudes following mystical-spiritual experiences. This unique and exciting potential mechanism of action certainly warrants the current renaissance in psychedelic research, and has important implications for study design and subject selection. As we move towards re-exploring the clinical applications of psychedelics, however, we must appreciate that the phenomenology of the psychedelic experience is likely to depend not only on a drug’s pharmacodynamic properties, but also on the makeup of the subject (‘set’) and the environmental context (‘setting’) in which the drug is administered. Recent work suggests that the potential importance of ‘set’ in the psychedelic experience should not be overlooked. Hallucinogenic compounds act via the serotonergic 5-HT2A receptor to effect experience and behaviour. Genetic and neuroimaging evidence suggests that inter-subject differences in serotonergic neurotransmission
    [Show full text]
  • Downloaded from by Pediatricsguest on October Vol.3, 2021 109 No
    Just a Click Away: Recreational Drug Web Sites on the Internet Paul M. Wax, MD ABSTRACT. The explosive growth of the Internet in sharp rise in MDMA use among college students as recent years has provided a revolutionary new means of well.3 The report of the Drug Abuse Warning Net- interpersonal communication and connectivity. Informa- work released in December 2000 reveals that emer- tion on recreational drugs—once limited to bookstores, gency department (ED) episodes related to MDMA, libraries, mass media, and personal contacts—is now GHB, and ketamine increased significantly during readily available to just about anyone with Internet ac- 4 cess. Not surprising, Internet access greatly facilitates the the period 1994 to 1999. In addition, abuse of some free and easy exchange of ideas, opinions, and unedited older drugs, such as dextromethorphan, seems to be 5 and nonrefereed information about recreational drugs. on the upsurge. This article presents a patient who came to medical at- Simultaneous with this “club” drug revolution has tention as the result of recreational drug-taking behavior been the explosive growth of the Internet. A dra- directly influenced by her Internet browsing. A second matic change in the everyday means of communica- case is presented in which the only information available tions has taken place. E-mail is now ubiquitous, and about the medical effects of a new “designer” drug was the World Wide Web, known as the Internet, brings found on a recreational drug Internet Web site. Several people together from all over the world attracted by such Web sites are described in detail.
    [Show full text]
  • Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismss
    Supplemental Material can be found at: /content/suppl/2020/12/18/73.1.202.DC1.html 1521-0081/73/1/202–277$35.00 https://doi.org/10.1124/pharmrev.120.000056 PHARMACOLOGICAL REVIEWS Pharmacol Rev 73:202–277, January 2021 Copyright © 2020 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license. ASSOCIATE EDITOR: MICHAEL NADER Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismss Antonio Inserra, Danilo De Gregorio, and Gabriella Gobbi Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montreal, Quebec, Canada Abstract ...................................................................................205 Significance Statement. ..................................................................205 I. Introduction . ..............................................................................205 A. Review Outline ........................................................................205 B. Psychiatric Disorders and the Need for Novel Pharmacotherapies .......................206 C. Psychedelic Compounds as Novel Therapeutics in Psychiatry: Overview and Comparison with Current Available Treatments . .....................................206 D. Classical or Serotonergic Psychedelics versus Nonclassical Psychedelics: Definition ......208 Downloaded from E. Dissociative Anesthetics................................................................209 F. Empathogens-Entactogens . ............................................................209
    [Show full text]
  • Ecstasy and Club Drugs
    Ecstasy and Club Drugs The term “club drug” refers to drugs being used by youth and young adults at all-night dance parties such as “raves” or “trances,” dance clubs and bars. MDMA (Ecstasy), GHB, Rohypnol, Ketamine, Methamphetamine, and LSD are among the drugs referred to as “club drugs.” “Raves” are a form of dance and recreation that is held in a clandestine location with fast-paced, high-volume music, a variety of high-tech entertainment and usually the use of “club drugs.” Ecstasy Ecstasy or MDMA (methylenedioxymethamphetamine) is a stimulant that combines the properties of methamphetamine or “speed” with mind-altering or hallucinogenic properties. It is considered to be the most commonly used club (or “designer” drug). Ecstasy is an illegal drug (it was declared illegal by the federal government in 1985) 90% of which is manufactured in the Netherlands and Belgium. In its most common form, Ecstasy is a small tablet that is impressed with any one of a number of logos intended to attract young people. It can also be in capsule or powder form and can be injected. Among the street names for Ecstasy are Adam, X-TC, Clarity, Essence, Stacy, Lover’s Speed, Eve, etc. The Ecstasy high can last from 6 to 24 hours, with the average “trip” lasting only about 3-4 hours. Users of Ecstasy report that it causes mood changed and loosens their inhibitions; they become more outgoing, empathetic and affectionate. For this reason, Ecstasy has been called the “hug drug.” It also suppresses the need to eat, drink or sleep, enabling users to endure parties that can last for two or three days.
    [Show full text]